Saga Pure ASA Boosts Stake in Vistin Pharma

Vistin Pharma ASA (DE:VP4) has released an update.

Saga Pure ASA increased its stake in Vistin Pharma ASA, acquiring 50,000 shares at a price of NOK 28.2 each, now holding a total of 700,000 shares. This purchase, conducted on the Oslo Stock Exchange, represents a 1.58% ownership in Vistin Pharma and is linked to board member Øystein Stray Spetalen.

For further insights into DE:VP4 stock, check out TipRanks’ Stock Analysis page.